|1.||Starlinraj, T: 1 article (02/2013)|
|2.||Uma, C: 1 article (02/2013)|
|3.||Gomathi, D: 1 article (02/2013)|
|4.||Narmadha, R: 1 article (02/2013)|
|5.||Gopalakrishnan, V K: 1 article (02/2013)|
|6.||Vidya, B: 1 article (02/2013)|
|7.||Raj, C Arul: 1 article (02/2013)|
|8.||Kalaivani, K: 1 article (02/2013)|
|9.||Kalaiselvi, M: 1 article (02/2013)|
|10.||Ragavendran, P: 1 article (02/2013)|
06/01/1996 - "These results suggested charge selectivity; however in five additional patients during peritonitis the peritoneal clearance of LDH 4/5 increased to 10 times the peritoneal clearance of LDH 1. Local LDH isoenzyme release from the cells present in the dialysate was shown to be responsible in stable and peritonitis patients. "
|2.||Diabetic Angiopathies (Diabetic Angiopathy)
|3.||Wounds and Injuries (Trauma)
01/01/1985 - "The appearance of LDH-4 isoenzyme in serum of thermally injured rats correlates linearly with indices of lung damage, supporting the results of previous studies suggesting that thermal trauma to the skin can cause oxygen radical production by complement-activated blood neutrophils with resultant acute microvascular injury in the lung interstitium. "
01/01/1991 - "On the other hand, the false-positive rate in patients with benign ovarian tumor was highest at LDH activity (12.7%), followed by HBD activity (10.0%), LDH-5 activity (8.6%), percent fraction of LDH-5 (8.2%), LDH-4 activity (6.8%) and percent fraction LDH-4 (3.6%). "
03/01/1983 - "Three of 4 patients with early cancer, who had normal serum LDH levels, showed abnormal LDH isozyme patterns (elevated LDH-4 and -5). "
01/01/1991 - "Serum LDH, LDH-4, LDH-5 and HBD in patients with ovarian carcinoma were significantly higher than those in patients with benign ovarian tumor. "
01/01/1989 - "In a group of patients from whom most of the tumor mass had been removed, LDH, LDH-4 and HBD significantly declined after the operation, whereas in a group of patients with a large residual tumor after operation no significant change in any of the serum tumor markers examined was observed after operation. "
02/01/2013 - "Expression of lactate dehydrogenase (LDH) isoenzymes shows an increase in the levels of LDH-4 and LDH-5 in cancer-bearing animals which is brought back to near normal. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
01/01/1989 - "From the analysis of predictive values for the recurrence of ovarian cancer, the most reliable tumor markers as a single marker appeared to be CA 125 and CEA, followed by ESR, LDH and LDH-4. "
11/01/1988 - "From analysis of linear regression, a negative correlation between LDH-1 or -2 and HBD activity in serum from patients with ovarian cancer was observed while there was a positive correlation between LDH-4 and HBD activity. "
01/01/1985 - "From analysis of serum LDH isoenzymes, a significant decrease in LDH-1, and significant increases in LDH-4 and LDH-5 in ovarian cancer patients were observed, when compared with those in patients with benign ovarian tumor. "
01/01/1989 - "Measurement of serum tumor markers [lactate dehydrogenase (LDH), alpha-hydroxybutyrate dehydrogenase (HBD), LDH-4, erythrocyte sedimentation rate (ESR), carcinoembryonic antigen (CEA), beta 2-microglobulin (beta 2M) and CA 125] was done before and after operation, and during the course of chemotherapy in 43 patients with advanced primary ovarian cancer. "
|1.||lactate dehydrogenase 3
|3.||Complement System Proteins (Complement)
|5.||lactate dehydrogenase 5
|6.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|7.||lactate dehydrogenase 1 (LDH1)
|8.||lactate dehydrogenase 2
|10.||Oleic Acid (Oleate)
|1.||Drug Therapy (Chemotherapy)